Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
Arthritis Care & Research · 16.08.2026
DOI: 10.1002/acr.80117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 16.08.2026. Verfasst von Kevin Byram und 25 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, Tennessee. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures. A VEXAS‐specific disease activity index (DAI) is an essential tool for reliably capturing changes in disease activity over time, thereby supporting clinical research and informing patient care in this emerging disease. This study aimed to develop a comprehensive DAI to assess disease‐related inflammation across affected organ systems in patients with VEXAS syndrome.
Methods
Inflammatory manifestations of VEXAS were previously identified through a systematic literature review and expert input. A multinational expert advisory committee developed the VEXAS‐DAI using modified Delphi methodology until consensus (defined as ≥75% concurrence) was reached. Item grading was adapted from the Common Terminology Criteria for Adverse Events. Scoring criteria were developed based on 158 test cases using the Physician Global Assessment of Inflammation.
Results
Consensus on the VEXAS‐DAI was achieved after four Delphi rounds. The index assesses inflammatory activity at the time of evaluation across 12 domains: inflammatory rash, chondritis, periorbital, ophthalmologic, joint, pulmonary, cardiovascular, genitourinary, neurologic, oral and gastrointestinal, renal, and constitutional symptoms. The total score ranges from 0 to 40.
Conclusion
The VEXAS‐DAI is a novel instrument designed to quantify active inflammation over time in patients with VEXAS. Prospective validation within a clinical trial setting is ongoing. image
Autor:innen und Institutionen
- Vanderbilt University Medical Center, Nashville, Tennessee.
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
- Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
- University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.
ORCID-Profile: Kevin Byram, Heřman Mann, Danielle Hammond, Onima Chowdhury, Sinisa Savic, Yohei Kirino, Carmelo Gurnari, Maël Heiblig, Thibault Comont, Arsène Mekinian, Lachelle D Weeks, Gary Ho, Adam Al-Hakim, Marcela A Ferrada, Sophie Georgin-Lavialle, Peter C Grayson, Emma M Groarke, Megan Sullivan, Sarah A Buckley, Bryan G Harder, Raman Garcha, David B Beck, Matthew J Koster
Zitieren
APA
Byram, K., Mann, H., Hammond, D., Chowdhury, O., Savic, S., Kirino, Y., Gurnari, C., Heiblig, M., Comont, T., Mekinian, A., Patnaik, M. M., Weeks, L. D., Ho, G., Al-Hakim, A., Goldberg, S., Ferrada, M. A., Georgin-Lavialle, S., Grayson, P. C., Groarke, E. M., …, & Koster, M. J. (2026). Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI). Arthritis Care & Research. https://doi.org/10.1002/acr.80117
Vancouver
Byram K, Mann H, Hammond D, Chowdhury O, Savic S, Kirino Y, et al. Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI). Arthritis Care & Research. 2026. doi:10.1002/acr.80117
BibTeX
@article{Byram2026,
author = {Byram, Kevin and Mann, Heřman and Hammond, Danielle and Chowdhury, Onima and Savic, Sinisa and Kirino, Yohei and Gurnari, Carmelo and Heiblig, Maël and Comont, Thibault and Mekinian, Arsène and Patnaik, Mrinal M and Weeks, Lachelle D and Ho, Gary and Al-Hakim, Adam and Goldberg, Scott and Ferrada, Marcela A and Georgin-Lavialle, Sophie and Grayson, Peter C and Groarke, Emma M and Patel, Bhavisha and Sullivan, Megan and Buckley, Sarah A and Harder, Bryan G and Garcha, Raman and Beck, David B and Koster, Matthew J},
title = {Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)},
journal = {Arthritis Care & Research},
year = {2026},
doi = {10.1002/acr.80117}
}
EUVIMED